Cardiome Pharma Corp (NASDAQ:CRME)

Delayed Data
As of Feb 27
 +0.03 / +0.31%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 12.50, with a high estimate of 14.00 and a low estimate of 5.00. The median estimate represents a +27.81% increase from the last price of 9.78.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 50.42%
Growthannually -328.91%


Growthquarterly 10.87%
Growthannually 595.35%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account